Literature DB >> 16556711

Quality of life in patients with benign thyroid disorders. A review.

Torquil Watt1, Mogens Groenvold, Ase Krogh Rasmussen, Steen Joop Bonnema, Laszlo Hegedüs, Jakob Bue Bjorner, Ulla Feldt-Rasmussen.   

Abstract

The importance of patient-reported outcomes such as health-related quality of life (HRQL) in clinical research is increasingly acknowledged. In order to yield valid results, the measurement properties of HRQL questionnaires must be thoroughly investigated. One aspect of such a validation process is the demonstration of content validity, i.e. that the questionnaire covers all relevant aspects. We review studies reporting on consequences of thyroid disorders and present the frequency of identified aspects, both overall HRQL issues and classical thyroid symptoms, in order to evaluate which issues are relevant for patients with thyroid diseases. Furthermore, existing questionnaires for thyroid patients are reviewed. A systematic search was performed in the Medline, Cinahl and Psycinfo databases and the reference lists of the relevant articles were hand-searched. Seventy-five relevant studies were identified. According to these studies, patients with untreated thyroid disease suffer from a wide range of symptoms and have major impairment in most areas of HRQL. Furthermore, the studies indicate that impairments in HRQL are also frequent in the long term. Six HRQL questionnaires for thyroid patients were identified. Generally, data supporting the validity of these questionnaires were sparse. According to the available literature, the quality of life of thyroid patients is substantially impaired over a wide range of aspects of HRQL in the untreated phase and continues to be so in many patients also in the long term. Studies systematically exploring the relative importance of these various aspects to thyroid patients are lacking, as is a comprehensive, validated thyroid-specific HRQL questionnaire.

Entities:  

Mesh:

Year:  2006        PMID: 16556711     DOI: 10.1530/eje.1.02124

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  61 in total

Review 1.  Targeted biological therapies for Graves' disease and thyroid-associated ophthalmopathy. Focus on B-cell depletion with Rituximab.

Authors:  Laszlo Hegedüs; Terry J Smith; Raymond S Douglas; Claus H Nielsen
Journal:  Clin Endocrinol (Oxf)       Date:  2011-01       Impact factor: 3.478

Review 2.  Evaluation of the methodological quality of systematic reviews of health status measurement instruments.

Authors:  Lidwine B Mokkink; Caroline B Terwee; Paul W Stratford; Jordi Alonso; Donald L Patrick; Ingrid Riphagen; Dirk L Knol; Lex M Bouter; Henrica C W de Vet
Journal:  Qual Life Res       Date:  2009-02-24       Impact factor: 4.147

3.  Ocular changes and approaches of ophthalmopathy in basedow - graves- parry- flajani disease.

Authors:  George Saraci; Anamaria Treta
Journal:  Maedica (Buchar)       Date:  2011-04

4.  Therapy: a new nonsurgical therapy option for benign thyroid nodules?

Authors:  Laszlo Hegedüs
Journal:  Nat Rev Endocrinol       Date:  2009-09       Impact factor: 43.330

5.  Assessment of swallowing function impairment in patients with benign goiters and impact of thyroidectomy: a case control study.

Authors:  Mayilvaganan Sabaretnam; Anjali Mishra; Gyan Chand; Gaurav Agarwal; Amit Agarwal; Ashok Kumar Verma; Saroj Kanta Mishra
Journal:  World J Surg       Date:  2012-06       Impact factor: 3.352

6.  Measuring quality of life in oculoplastic patients.

Authors:  Edward Ridyard; Clare Inkster
Journal:  Int J Ophthalmol       Date:  2014-02-18       Impact factor: 1.779

7.  Does thyroid surgery for Graves' disease improve health-related quality of life?

Authors:  Gregorio Scerrino; Giuditta Morfino; Nunzia Cinzia Paladino; Valentina Di Paola; Emanuele Amodio; Gaspare Gulotta; Sebastiano Bonventre
Journal:  Surg Today       Date:  2012-12-11       Impact factor: 2.549

8.  Thyroid hormone status and health-related quality of life in the LifeLines Cohort Study.

Authors:  Elise I Klaver; Hannah C M van Loon; Riejanne Stienstra; Thera P Links; Joost C Keers; Ido P Kema; Anneke C Muller Kobold; Melanie M van der Klauw; Bruce H R Wolffenbuttel
Journal:  Thyroid       Date:  2013-09       Impact factor: 6.568

9.  Establishing construct validity for the thyroid-specific patient reported outcome measure (ThyPRO): an initial examination.

Authors:  Torquil Watt; Jakob Bue Bjorner; Mogens Groenvold; Ase Krogh Rasmussen; Steen Joop Bonnema; Laszlo Hegedüs; Ulla Feldt-Rasmussen
Journal:  Qual Life Res       Date:  2009-03-14       Impact factor: 4.147

10.  Improving a newly developed patient-reported outcome for thyroid patients, using cognitive interviewing.

Authors:  Torquil Watt; Ase Krogh Rasmussen; Mogens Groenvold; Jakob Bue Bjorner; Sara Hope Watt; Steen Joop Bonnema; Laszlo Hegedüs; Ulla Feldt-Rasmussen
Journal:  Qual Life Res       Date:  2008-06-27       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.